Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Evidence to recommendations for pre-exposure vaccination with rVSVΔG-ZEBOV-GP vaccine for at-risk adults in the United States
Filetype[PDF-1.21 MB]


Details:
  • Supporting Files:
    No Additional Files
    1. ACIP Ebola Virus Vaccine Work Group
      Personal Author:
      Frey, Sharon
      Corporate Authors:
      ACIP Ebola Virus Vaccine Work Group.. Saint Louis University Medical School..
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)
      Published Date:
      February 6, 2020
      Series:
      ACIP meeting Ebola Vaccine
      Description:
      Ebola-01-Frey-508.pdf
      File Type:
      Filetype[PDF - 453.15 KB]
    2. Influenza session
      Personal Author:
      Atmar, Robert L.
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Influenza Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      February 6, 2020
      Series:
      ACIP meeting Influenza
      Description:
      flu-01-Atmar-508.pdf
      File Type:
      Filetype[PDF - 167.12 KB]
    3. Grading of Recommendations Assessment, Development and Evaluation (GRADE): rVSVΔG-ZEBOV-GP Ebola vaccine
      Personal Author:
      Cossaboom, Caitlin M.
      Corporate Authors:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)
      Published Date:
      February 6, 2020
      Series:
      ACIP meeting Ebola Vaccine
      Description:
      Ebola-03-Cossaboom-508.pdf
      File Type:
      Filetype[PDF - 1.16 MB]
    4. Background
      Personal Author:
      Choi, Mary
      Corporate Authors:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)
      Published Date:
      February 6, 2020
      Series:
      ACIP meeting Ebola Vaccine
      Description:
      Ebola-02-Choi-508.pdf
      File Type:
      Filetype[PDF - 1.93 MB]
    5. Interim estimates of 2019–20 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network
      Corporate Authors:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      February 6, 2020
      Series:
      ACIP meeting Influenza
      Description:
      flu-04-Flannery-508.pdf
      File Type:
      Filetype[PDF - 584.68 KB]
    6. Older adult (65+) adjuvanted quadrivalent influenza vaccine (aIIV4) phase III trial
      Personal Author:
      Sylvester, Gregg C.
      Corporate Authors:
      Seqirus.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      February 6, 2020
      Series:
      ACIP meeting Influenza
      Description:
      flu-02-Sylvester-508.pdf
      File Type:
      Filetype[PDF - 1012.51 KB]
    7. Work Group considerations : proposed rcommendation text for policy options
      Personal Author:
      Choi, Mary
      Corporate Authors:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)
      Published Date:
      February 6, 2020
      Series:
      ACIP meeting Ebola Vaccine
      Description:
      Ebola-05-Choi-508.pdf
      File Type:
      Filetype[PDF - 570.22 KB]
    8. Summary and Work Group considerations
      Personal Author:
      Grohskopf, Lisa A.
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      February 6, 2020
      Series:
      ACIP meeting Influenza
      Description:
      flu-06-Grohskopf-508.pdf
      File Type:
      Filetype[PDF - 386.24 KB]
    9. Influenza surveillance update
      Personal Author:
      Brammer, Lynnette
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). US Flu VE Network.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      February 6, 2020
      Series:
      ACIP meeting Influenza
      Description:
      /lu-03-Brammer-508.pdf
      File Type:
      Filetype[PDF - 1.00 MB]
You May Also Like:
  1. Grading of Recommendations Assessment, Development and Evaluation (GRADE): rVSVΔG-ZEBOV-GP Ebola vaccine
    Personal Author:
    Cossaboom, Caitlin M.
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)
    Published Date:
    February 6, 2020
    Series:
    ACIP meeting Ebola Vaccine
    Description:
    Ebola-03-Cossaboom-508.pdf
    File Type:
    Filetype[PDF - 1.16 MB]
  2. Background
    Personal Author:
    Choi, Mary
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)
    Published Date:
    February 6, 2020
    Series:
    ACIP meeting Ebola Vaccine
    Description:
    Ebola-02-Choi-508.pdf
    File Type:
    Filetype[PDF - 1.93 MB]
  3. ACIP Ebola Virus Vaccine Work Group
    Personal Author:
    Frey, Sharon
    Corporate Authors:
    ACIP Ebola Virus Vaccine Work Group.. Saint Louis University Medical School..
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)
    Published Date:
    February 6, 2020
    Series:
    ACIP meeting Ebola Vaccine
    Description:
    Ebola-01-Frey-508.pdf
    File Type:
    Filetype[PDF - 453.15 KB]
  4. Work Group considerations : proposed rcommendation text for policy options
    Personal Author:
    Choi, Mary
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)
    Published Date:
    February 6, 2020
    Series:
    ACIP meeting Ebola Vaccine
    Description:
    Ebola-05-Choi-508.pdf
    File Type:
    Filetype[PDF - 570.22 KB]
  5. Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola
    Personal Author:
    Legardy-Williams, Jennifer K.; Carter, Rosalind J.; Goldstein, Susan T.; Jarrett, Olamide D.; Szefer, Elena; Fombah, Augustin E.; Tinker, Sarah C.; Samai, Mohamed; Mahon, Barbara E.;
    Published Date:
    March 17 2020
    Source:
    Emerg Infect Dis. 26(3):541-548
    Description:
    Little information exists regarding Ebola vaccine rVSVΔG-ZEBOV-GP and pregnancy. The Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE) randomized participants without blinding to immediate or deferred (18-24 weeks postenrollment) vacc...
    File Type:
    Filetype[PDF - 1.30 MB]